Cardiomyopathy With Frequent Ventricular Premature Depolarization – Predicting Irreversible Ventricular Dysfunction

Kyoung-Min Park1, Jihye Kim, Hayoung Na

  • 1Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine.

Insights

Frequent ventricular premature depolarization (VPD) can cause left ventricular (LV) dysfunction. Left ventricular end-diastolic dimension (LVEDD) greater than 66 mm before ablation predicts irreversible LV cardiomyopathy (CMP) after successful VPD suppression.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiomyopathy Research

Background:

  • High burden of ventricular premature depolarization (VPD) is linked to left ventricular (LV) dysfunction.
  • LV dysfunction typically resolves post-ablation, but some patients experience persistent dysfunction.
  • Identifying predictors of irreversible LV cardiomyopathy (CMP) is crucial for patient outcomes.

Purpose of the Study:

  • To identify factors predicting irreversible left ventricular (LV) cardiomyopathy (CMP) in patients with frequent ventricular premature depolarization (VPD).
  • To evaluate the role of left ventricular end-diastolic dimension (LVEDD) in predicting persistent LV dysfunction after successful VPD suppression.

Main Methods:

  • Retrospective analysis of 57 patients with frequent VPD (>10%/day) undergoing successful radiofrequency (RF) ablation.
  • Patients were categorized based on LV function normalization post-ablation using transthoracic echocardiography (TTE).
  • Comparison of clinical, electrocardiographic, and TTE parameters, focusing on LV dimensions (LVEDD, LVESD).

Main Results:

  • Significant differences in pre-ablation LVEDD and LV end-systolic dimension between groups with reversible and irreversible LV dysfunction.
  • Pre-suppression LVEDD ≤66 mm was observed in all patients with reversible CMP.
  • LVEDD >66 mm demonstrated high specificity (100%) and positive predictive value (100%) for irreversible CMP.

Conclusions:

  • Left ventricular end-diastolic dimension (LVEDD) is a significant predictor of irreversible left ventricular cardiomyopathy (LV CMP) in patients with frequent ventricular premature depolarization (VPD).
  • An LVEDD >66 mm effectively predicts irreversible CMP with high specificity after successful VPD suppression.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
801
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
848
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
884
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
695
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
4.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767